Literature DB >> 10764922

The role of serotonin(2) receptors in mediating cocaine-induced convulsions.

L E O'Dell1, M J Kreifeldt, F R George, M C Ritz.   

Abstract

Previous research in our laboratory suggests that serotonin (5-HT) neurotransmission mediates the expression of cocaine-induced convulsions. The role of 5-HT in mediating this toxic effect of cocaine appears to be due to activation of 5-HT(2) receptors, because cocaine-induced convulsions are blocked by the 5-HT(2) antagonists cinanserin, ketanserin, and pirenperone. The present study utilized a number of compounds that display a high affinity for 5-HT(2) receptors to further examine the role of these sites in mediating this toxic effect of cocaine. Cocaine-induced convulsions were observed following pretreatment with various doses of the following 5-HT(2) antagonists: mianserin, metergoline, MDL 11939, and methiothepin. In addition, 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine (NAN 190) was tested to examine the influence of 5-HT(1) sites and the agonist compound 1-(3-triflurormethylphenyl)piperazine (TFMPP) was examined to further explore the role of 5-HT(1) and 5-HT(2) sites. Each 5-HT(2) antagonist attenuated cocaine-induced convulsions. Conversely, NAN 190 did not alter this toxic effect of cocaine. In addition, TFMPP significantly potentiated cocaine-induced convulsions. The results from this study support the hypothesis that 5-HT neurotransmission, acting primarily at 5-HT(2) receptors, plays an important role in mediating cocaine-induced convulsions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764922     DOI: 10.1016/s0091-3057(99)00253-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

1.  Elevated serotonergic signaling amplifies synaptic noise and facilitates the emergence of epileptiform network oscillations.

Authors:  Pavel A Puzerey; Michael J Decker; Roberto F Galán
Journal:  J Neurophysiol       Date:  2014-08-13       Impact factor: 2.714

2.  M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.

Authors:  Azizi Ray; Clinton E Canal; J Christopher Ehlen; Kenner C Rice; Kevin Sean Murnane
Journal:  Neurotoxicology       Date:  2019-06-01       Impact factor: 4.294

3.  Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine.

Authors:  Alison A Williams; Wendy M Ingram; Sarah Levine; Jack Resnik; Christy M Kamel; James R Lish; Diana I Elizalde; Scott A Janowski; Joseph Shoker; Alexey Kozlenkov; Javier González-Maeso; Amelia L Gallitano
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

Review 4.  The role of different serotonin receptor subtypes in seizure susceptibility.

Authors:  Mohammad Hadi Gharedaghi; Mohammad Seyedabadi; Jean-Eric Ghia; Ahmad Reza Dehpour; Reza Rahimian
Journal:  Exp Brain Res       Date:  2013-11-14       Impact factor: 1.972

5.  Does Serotonin Play a Role in Epilepsy?

Authors:  William H. Theodore
Journal:  Epilepsy Curr       Date:  2003-09       Impact factor: 7.500

6.  Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures.

Authors:  Meriem Gaval-Cruz; Jason P Schroeder; L Cameron Liles; Martin A Javors; David Weinshenker
Journal:  Pharmacol Biochem Behav       Date:  2008-02-12       Impact factor: 3.533

7.  Preventative effects of aripiprazole and quetiapine on seizure and lethality in a mice cocaine toxicity model: an experimental study.

Authors:  Atakan Yilmaz; Bulent Erdur; Mert Ozen; Ramazan Sabirli; Ibrahim Turkcuer; Ahmet Sarohan; Murat Seyit
Journal:  J Int Med Res       Date:  2019-06-12       Impact factor: 1.671

8.  Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity, and learning deficits in a fragile X model.

Authors:  Chae-Seok Lim; Elizabeth T Hoang; Kenneth E Viar; Ruth L Stornetta; Michael M Scott; J Julius Zhu
Journal:  Genes Dev       Date:  2014-02-01       Impact factor: 11.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.